Supplemental Figure 1A: RAW BMI MALES

Nov 19, 2014

10 likes | 94 Views

Supplemental Figure 1A: RAW BMI MALES. 95 TH. 50 TH. 5 TH. BMI. AGE (y).

Share Presentation

Embed Code

Link

alden-ortiz

Download Presentation

Supplemental Figure 1A: RAW BMI MALES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Supplemental Figure 1A: RAW BMI MALES 95TH 50TH 5TH BMI AGE (y)

Supplemental Figure 1 .

Supplemental Figure 1 . mGlu1 α Receptor. A. IgG. 100. 80. DAPI. Co-localization of markers/CTX (%). 60. B. GM1. Transferrin receptor. 40. 20. Transferrin receptor. GM1. CTX. Supplemental Figure 2. A. Tat-blocking. Tat-mutant. Control. IP : mGlu1 α. Caveolin. mGlu1 α.

102 views • 2 slides

Supplemental Figure 1

Supplemental Figure 1. BMP2 expression at 24 hours post transduction in ovine MSCs.

108 views • 1 slides

Supplemental Figure 1

Supplemental Figure 1. Nomoxia. CH. Supplemental Fig 1. Vascular remodeling in rats for pulmonary arterial hypertension (PAH ). Weigert’s elastic staining revealed medial thickening changes in lungs . CH, chronically hypoxic . Supplemental Figure 2. ET A R. b -actin. CH. Normoxia.

180 views • 2 slides

-- 1353/1078/872 -- 603 -- 310 -- 281/271 -- 234 -- 194 -- 118 -- 72

Supplemental Figure 1 A and B: Specificity validation of the PCR products Supplemental Figure 1A: Agarose gel electrophoresis of qPCR amplicons Gel strength: 4% NuSieve GTG (FMC Bioproducts, Rockland, ME) low melting temperature agarose

177 views • 2 slides

Supplemental Figure 1

Supplemental Figure 1. A. Mock. MOI-100. MOI-10. 0.5%. 79.7%. 21.8%. CD3 PerCP. NY-ESO-1 Tetramer PE. B. C. Supplemental Figure 2. A. Thymus. L Humerus. R Humerus. Muscle. L Femur. R Femur. C. B. P < 0.0001. Supplemental Figure 3. A. B.

154 views • 3 slides

Supplemental Figure 3

Supplemental Figure 3. Time course of mean arterial pressure, albuminuria, and kidney injury after reduction in renal mass and treatment of C57BL/6 mice with deoxycorticosterone acetate + saline drinking water (DOCA) or treatment of CD-1 mice with hydralazine.

133 views • 1 slides

Supplemental Figure 2.

MS/MS spectrum of a single peptide that identified a protein. The b and y ion series, ion scores, and ranking in the Mascot search were manually inspected. Supplemental Figure 2. Spot 6069. Spot 5331. Spot 3696. Spot 5018. Spot 4068.

215 views • 6 slides

Supplemental figure 1

Supplemental figure 1. 60. 40. 20. 0. control. MBZ 0.2 μ M. MBZ 0.1  M. A. B. Con MBZ 0.1 0.2 m M 72h. P S P S P S. a - a Tub. % polymerised tubulin. a - b Act. Supplemental figure 2. previous exp.

123 views • 2 slides

Supplemental Figure 2

Supplemental Figure 2. Supplemental Figure 2. Combined use of crizotinib or TAS-115 with erlotinib reverses resistance to EGFR-TKI induced by exogenous HGF on HCC827 cell.

166 views • 1 slides

Supplemental Figure 2

Supplemental Figure 2. FEMALES. MALES. A. **. **. **. **. BARNES. 3. 3. *. ##. M. M. B. $. $. 18. M. C. *. HPWM.

94 views • 1 slides

Supplemental Figure Fung et al.

Supplemental Figure Fung et al. A. B. Fluorescence and phase-contrast microscopic images showing ( A ) co-culture of MS5-GFP cells with human primary macrophages (including those encircled red). Note stellate network of MS5 cells (white arrows) spanning across an

145 views • 1 slides

Supplemental Figure 1.

Supplemental Figure 1. A. GCN1L1. B. DSP. C. RCN3. D. AKR1B10. E. PDIA4. F. CTSB. Supplemental Figure 1. Cont. G. EIF5A. H. SERPINB5. I. TPD52. Supplemental Figure 2. A. Biological process. B. Cellular component. Supplemental Figure 3. A. C. B. A549. Cont. Sh1. Cont. Sh1.

217 views • 6 slides

Supplemental Figure 3

Supplemental Figure 3: Relationship between transcript heritability H and eQTL sum R 2 plotted on hexbin graphs.

139 views • 1 slides

Kraenzlin et al. Supplemental Figure 1

µV. 2.0e+5. PYD. 1.5e+5. ISTD. Fluorescence (295/400 nm). 1.0e+5. DPD. 0.5e+4. 0.0. -0.5e+4. 2. 4. 6. 8. 10. 12. Time (min). Kraenzlin et al. Supplemental Figure 1. Supplemental Figure 1:

99 views • 1 slides

Figure S1 Rink et al 2009

A. B. C. D. 30. LMCA. RMCA. a. 20. Percent hemispherical lesion volume. 10. E. 0. TTC. MRI. iNBO. iHBO. supplemental O 2 during ischemia. RA (control). rNBO. rHBO. supplemental O 2 at reperfusion. Figure S1 Rink et al 2009.

121 views • 1 slides

Supplemental images for Oklahoma archeology 56(2)

Supplemental images for Oklahoma archeology 56(2). Supplemental images for Oklahoma archeology 56(2). Figure 5. excavation of knoll c at 34lf596; view north. Supplemental images for Oklahoma archeology 56(2). Figure 7. feature 2 rock clusters; view south.

212 views • 9 slides

Supplemental Figure 1

Supplemental Figure 1. A. B. Inhibitors concentration (µM).

148 views • 6 slides

Supplemental figure 1

2.5. *. 2.0. 1.5. LC3-II protein level. 1.0. 0.5. Ctrl. Pi. Supplemental figure 1. a. b. Ctrl Pi (3 mM). LC3I. LC3II. 50.  -actin. *. 40. 30. %Cells with GFP-LC3 puncta. 20. 10. Ctrl. Pi.

187 views • 7 slides

Supplemental Figure 1 .

Supplemental Figure 1. mGlu1 α Receptor. A. IgG. 100. 80. DAPI. Co-localization of markers/CTX (%). 60. B. GM1. Transferrin receptor. 40. 20. Transferrin receptor. GM1. CTX. Supplemental Figure 2. A. Tat-blocking. Tat-mutant. Control. IP : mGlu1 α. Caveolin. mGlu1 α.

125 views • 2 slides

Supplemental Figure 1

2500. 2000. 1500. 1000. 500. Supplemental Figure 1. CS-0777 product [ ng/mL ･ mg protein ]. 0. #1. #2. #3. #4. #5. Human specimen number. Supplemental figure 1. Examination of individual specificity of CS-0777-P phosphatase activity

230 views • 7 slides

More Related